+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Tissue Engineering Market Research Report by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4989887
  • Report
  • July 2021
  • Region: Global
  • 198 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Tissue Engineering Market will Grow to USD 72.25 Billion by 2026, at a CAGR of 18.63%

FEATURED COMPANIES

  • BASF SE
  • Corning Incorporated
  • Medtronic PLC
  • Organogenesis Inc
  • ReproCell Inc.
  • Stryker Corporation
  • MORE
The Global Tissue Engineering Market size was estimated at USD 25.92 Billion in 2020 and expected to reach USD 30.66 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 18.63% to reach USD 72.25 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Tissue Engineering to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Application, the Tissue Engineering Market was studied across Cancer, Cardiology, Cord Blood & Cell Banking, Dental, GI & Gynaecology, Neurology, Orthopedics, Musculoskeletal, and Spine, Skin/Integumentary, Urology, and Organ Replacement, Transplants & Ophthalmology.
  • Based on Material, the Tissue Engineering Market was studied across Biomimetic Material, Composite Material, Nano-Composite Material, and Nano-Fibrous Material.
  • Based on Region, the Tissue Engineering Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Tissue Engineering Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Tissue Engineering Market, including BASF SE, Bayer AG, Cook Medical Inc, Corning Incorporated, General Electric Company, Integra LifeSciences Corporation, Johnson & Johnson, Medtronic PLC, Merck KGaA, Novartis AG, Organogenesis Inc, Organovo Holdings, Inc., Pfizer Inc, ReproCell Inc., Siemens AG, Smith & Nephew PLC, Stryker Corporation, Tissue Regenix Group PLC, Vericel Corporation, and Zimmer Biomet Holdings, Inc.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Tissue Engineering Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Tissue Engineering Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Tissue Engineering Market?
4. What is the competitive strategic window for opportunities in the Global Tissue Engineering Market?
5. What are the technology trends and regulatory frameworks in the Global Tissue Engineering Market?
6. What is the market share of the leading vendors in the Global Tissue Engineering Market?
7. What modes and strategic moves are considered suitable for entering the Global Tissue Engineering Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BASF SE
  • Corning Incorporated
  • Medtronic PLC
  • Organogenesis Inc
  • ReproCell Inc.
  • Stryker Corporation
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Material Outlook
3.5. Region Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Potential use of tissue engineering procedures in treating irreversible damage of tissues
5.1.1.2. Need for effective regenerative treatments owing to a rise in the prevalence of diabetes, obesity, and other lifestyle related disorders
5.1.1.3. Increasing prevalence of kidney related disorders
5.1.2. Restraints
5.1.2.1. Lack of suitable biomaterials and techniques for capturing appropriate physiological architectures
5.1.3. Opportunities
5.1.3.1. Technological advancements in the field of 3D tissue engineering
5.1.3.2. Increase in government funding for medical and academic research activities
5.1.3.3. Rapid advances in stem cell research aid in improved disease management
5.1.3.4. Surge in R&D activities to develop tissue engineered products for cardiology
5.1.4. Challenges
5.1.4.1. Stringent government regulations and high cost of treatment
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Tissue Engineering Market, by Application
6.1. Introduction
6.2. Cancer
6.3. Cardiology
6.4. Cord Blood & Cell Banking
6.5. Dental
6.6. GI & Gynaecology
6.7. Neurology
6.8. Orthopedics, Musculoskeletal, and Spine
6.9. Skin/Integumentary
6.10. Urology
6.11. Organ Replacement, Transplants & Ophthalmology

7. Tissue Engineering Market, by Material
7.1. Introduction
7.2. Biomimetic Material
7.3. Composite Material
7.4. Nano-Composite Material
7.5. Nano-Fibrous Material

8. Americas Tissue Engineering Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Tissue Engineering Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand

10. Europe, Middle East & Africa Tissue Engineering Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. BASF SE
12.2. Bayer AG
12.3. Cook Medical Inc
12.4. Corning Incorporated
12.5. General Electric Company
12.6. Integra LifeSciences Corporation
12.7. Johnson & Johnson
12.8. Medtronic PLC
12.9. Merck KGaA
12.10. Novartis AG
12.11. Organogenesis Inc
12.12. Organovo Holdings, Inc.
12.13. Pfizer Inc
12.14. ReproCell Inc.
12.15. Siemens AG
12.16. Smith & Nephew PLC
12.17. Stryker Corporation
12.18. Tissue Regenix Group PLC
12.19. Vericel Corporation
12.20. Zimmer Biomet Holdings, Inc

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL TISSUE ENGINEERING MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
FIGURE 3. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY MATERIAL, 2020 (USD BILLION)
FIGURE 4. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 5. GLOBAL TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 6. GLOBAL TISSUE ENGINEERING MARKET: MARKET DYNAMICS
FIGURE 7. GLOBAL TISSUE ENGINEERING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 8. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 9. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2026
FIGURE 11. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CANCER, 2018-2026 (USD BILLION)
FIGURE 12. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CANCER, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 13. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CARDIOLOGY, 2018-2026 (USD BILLION)
FIGURE 14. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 15. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CORD BLOOD & CELL BANKING, 2018-2026 (USD BILLION)
FIGURE 16. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CORD BLOOD & CELL BANKING, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 17. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY DENTAL, 2018-2026 (USD BILLION)
FIGURE 18. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY DENTAL, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 19. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY GI & GYNAECOLOGY, 2018-2026 (USD BILLION)
FIGURE 20. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY GI & GYNAECOLOGY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 21. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY NEUROLOGY, 2018-2026 (USD BILLION)
FIGURE 22. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY NEUROLOGY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 23. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY ORTHOPEDICS, MUSCULOSKELETAL, AND SPINE, 2018-2026 (USD BILLION)
FIGURE 24. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY ORTHOPEDICS, MUSCULOSKELETAL, AND SPINE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 25. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY SKIN/INTEGUMENTARY, 2018-2026 (USD BILLION)
FIGURE 26. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY SKIN/INTEGUMENTARY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 27. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY UROLOGY, 2018-2026 (USD BILLION)
FIGURE 28. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY UROLOGY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 29. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY ORGAN REPLACEMENT, TRANSPLANTS & OPHTHALMOLOGY, 2018-2026 (USD BILLION)
FIGURE 30. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY ORGAN REPLACEMENT, TRANSPLANTS & OPHTHALMOLOGY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 31. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY MATERIAL, 2020 VS 2026 (%)
FIGURE 32. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY MATERIAL, 2020 VS 2026 (USD BILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TISSUE ENGINEERING MARKET SIZE, BY MATERIAL, 2026
FIGURE 34. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY BIOMIMETIC MATERIAL, 2018-2026 (USD BILLION)
FIGURE 35. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY BIOMIMETIC MATERIAL, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 36. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COMPOSITE MATERIAL, 2018-2026 (USD BILLION)
FIGURE 37. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COMPOSITE MATERIAL, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 38. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY NANO-COMPOSITE MATERIAL, 2018-2026 (USD BILLION)
FIGURE 39. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY NANO-COMPOSITE MATERIAL, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 40. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY NANO-FIBROUS MATERIAL, 2018-2026 (USD BILLION)
FIGURE 41. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY NANO-FIBROUS MATERIAL, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 42. AMERICAS TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 43. ARGENTINA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 44. BRAZIL TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 45. CANADA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. MEXICO TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. UNITED STATES TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. CHINA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. INDIA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. INDONESIA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. JAPAN TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. MALAYSIA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. SINGAPORE TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. THAILAND TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. FRANCE TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. GERMANY TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. ITALY TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. QATAR TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. RUSSIA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 66. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 67. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 68. SPAIN TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 69. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 70. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 71. GLOBAL TISSUE ENGINEERING MARKET: FPNV POSITIONING MATRIX
FIGURE 72. GLOBAL TISSUE ENGINEERING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 73. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TISSUE ENGINEERING MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL TISSUE ENGINEERING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CANCER, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CORD BLOOD & CELL BANKING, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY DENTAL, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY GI & GYNAECOLOGY, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY ORTHOPEDICS, MUSCULOSKELETAL, AND SPINE, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY SKIN/INTEGUMENTARY, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY UROLOGY, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY ORGAN REPLACEMENT, TRANSPLANTS & OPHTHALMOLOGY, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY MATERIAL, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY BIOMIMETIC MATERIAL, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COMPOSITE MATERIAL, BY REGION, 2018-2026 (USD BILLION)
TABLE 18. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY NANO-COMPOSITE MATERIAL, BY REGION, 2018-2026 (USD BILLION)
TABLE 19. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY NANO-FIBROUS MATERIAL, BY REGION, 2018-2026 (USD BILLION)
TABLE 20. AMERICAS TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 21. ARGENTINA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. BRAZIL TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. CANADA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. MEXICO TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. UNITED STATES TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. CHINA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. INDIA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. INDONESIA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. JAPAN TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. MALAYSIA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. SINGAPORE TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. THAILAND TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. FRANCE TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. GERMANY TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. ITALY TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. QATAR TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. RUSSIA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. SPAIN TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 47. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 48. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 49. GLOBAL TISSUE ENGINEERING MARKET: SCORES
TABLE 50. GLOBAL TISSUE ENGINEERING MARKET: BUSINESS STRATEGY
TABLE 51. GLOBAL TISSUE ENGINEERING MARKET: PRODUCT SATISFACTION
TABLE 52. GLOBAL TISSUE ENGINEERING MARKET: RANKING
TABLE 53. GLOBAL TISSUE ENGINEERING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 54. GLOBAL TISSUE ENGINEERING MARKET: MERGER & ACQUISITION
TABLE 55. GLOBAL TISSUE ENGINEERING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 56. GLOBAL TISSUE ENGINEERING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 57. GLOBAL TISSUE ENGINEERING MARKET: INVESTMENT & FUNDING
TABLE 58. GLOBAL TISSUE ENGINEERING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 59. GLOBAL TISSUE ENGINEERING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • BASF SE
  • Bayer AG
  • Cook Medical Inc
  • Corning Incorporated
  • General Electric Company
  • Integra LifeSciences Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merck KGaA
  • Novartis AG
  • Organogenesis Inc
  • Organovo Holdings, Inc.
  • Pfizer Inc
  • ReproCell Inc.
  • Siemens AG
  • Smith & Nephew PLC
  • Stryker Corporation
  • Tissue Regenix Group PLC
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll